Cibc Asset Management Inc Moderna, Inc. Transaction History

Cibc Asset Management Inc

$27.8 Billion
Q1 2025

A detailed history of Cibc Asset Management Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Cibc Asset Management Inc holds 52,338 shares of MRNA stock, worth $1.37 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

52,338

Previous 52,904 1.07%

Holding current value

$1.37 Million

Previous $2.2 Million 32.56%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$28.35 - $47.53 $16,046 - $26,901	-566 Reduced 1.07%	52,338 $1.48 Million
Q4 2024 Jan 31, 2025	SELL	$36.85 - $63.93 $2.24 Million - $3.89 Million	-60,918 Reduced 53.52%	52,904 $2.2 Million
Q3 2024 Nov 06, 2024	BUY	$63.64 - $125.14 $432,370 - $850,201	6,794 Added 6.35%	113,822 $7.61 Million
Q2 2024 Aug 01, 2024	BUY	$101.21 - $166.61 $127,220 - $209,428	1,257 Added 1.19%	107,028 $12.7 Million
Q1 2024 May 09, 2024	BUY	$85.37 - $115.44 $515,549 - $697,142	6,039 Added 6.06%	105,771 $11.3 Million
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $43,513 - $65,373	626 Added 0.63%	99,732 $9.92 Million
Q3 2023 Oct 30, 2023	BUY	$96.41 - $126.61 $915,220 - $1.2 Million	9,493 Added 10.59%	99,106 $10.2 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $64,582 - $87,488	-545 Reduced 0.6%	89,613 $10.9 Million
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $136,609 - $198,399	-1,007 Reduced 1.1%	90,158 $13.8 Million
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $251,083 - $445,494	-2,121 Reduced 2.27%	91,165 $16.4 Million
Q3 2022 Nov 03, 2022	BUY	$118.07 - $194.18 $325,046 - $534,577	2,753 Added 3.04%	93,286 $11 Million
Q2 2022 Aug 09, 2022	BUY	$117.13 - $176.59 $57,862 - $87,235	494 Added 0.55%	90,533 $12.9 Million
Q1 2022 May 06, 2022	SELL	$126.46 - $235.05 $71,829 - $133,508	-568 Reduced 0.63%	90,039 $15.5 Million
Q4 2021 Feb 08, 2022	BUY	$225.82 - $368.51 $1.73 Million - $2.82 Million	7,651 Added 9.22%	90,607 $23 Million
Q3 2021 Nov 09, 2021	BUY	$221.9 - $484.47 $6.76 Million - $14.7 Million	30,443 Added 57.97%	82,956 $31.9 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $258,520 - $467,610	1,990 Added 3.94%	52,513 $12.3 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $788,497 - $1.34 Million	7,222 Added 16.68%	50,523 $6.62 Million
Q4 2020 Feb 03, 2021	BUY	$65.74 - $169.86 $277,094 - $715,959	4,215 Added 10.78%	43,301 $4.52 Million
Q3 2020 Nov 05, 2020	BUY	$54.34 - $94.85 $1.46 Million - $2.55 Million	26,903 Added 220.82%	39,086 $2.77 Million
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $169,709 - $259,254	12,183 New	12,183 $238,000

Others Institutions Holding MRNA

# of Institutions

874

Shares Held

255M

Call Options Held

24M

Put Options Held

31.3M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $10.2B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Account

Cibc Asset Management Inc Moderna, Inc. Transaction History